Ž y . Objective: Previous studies suggest a role of superoxide anion radicals PO in impaired endothelium-dependent relaxation of 2 diabetic blood vessels; however, the role of secondary reactive oxygen species remains unclear. In the present study, we investigated a role of various potential reactive oxygen species in diabetic endothelial dysfunction. Methods: Thoracic aortic rings from 8-week streptozotocin-induced diabetic and age-matched control rats were mounted in isolated tissue baths. Endothelium-dependent relaxation to Ž . Ž . acetylcholine ACH and endothelium-independent relaxation to nitroglycerin NTG were assessed in precontracted rings. Results: ACH-induced relaxation was impaired in diabetic compared to control rings and was not improved with either indomethacin or daltroban. ACH-induced relaxation in both control and diabetic rings was completely blocked with the nitric oxide synthase inhibitors, Ž . L -nitroarginine methyl ester or L-nitroarginine L-NA . NTG-induced relaxation was insensitive to L-NA and was unaltered by diabetes.
Introduction
Both macrovascular and microvascular disease are significant complications of diabetes mellitus. It is possible that the endothelial cell may play a pivotal role in the development of both macrovascular and microvascular disease in diabetes mellitus.
The endothelial cell is an important source of produc-Ž . tion of endothelium-derived relaxing factor EDRF , a Ž . substance believed to be nitric oxide NO or a closely-re- w x resistance 9-11 arteries of experimental diabetic animals. This vascular defect has now been documented in both w x w x Type I 12,13 and Type II 14 diabetic patients.
The mechanism of endothelial dysfunction in diabetes mellitus in humans is not yet known with certainty. Therefore, detailed investigations conducted in experimental diabetic models may provide clues to the mechanism of this dysfunction. While various potential mechanisms have been proposed, a single unifying mechanism to account for endothelial dysfunction in diabetes has yet to emerge.
Previous work from our laboratory suggests that pre-Ž . treatment with superoxide dismutase SOD enhances basal and agonist-stimulated EDRF activity arising from perw x fused diabetic rat aorta 15, 16 . This suggests that diabetic rat endothelium produces an enhanced rate of PO y genera-2 tion. It is important to underscore the fact that the PO y is 2 an initial oxygen radical species which may lead to secondary radicals or reactive oxygen species such as H O 2 2 Ž . or POH Fig. 1 . Currently, there is insufficient information available to exclude the possibility that secondary radicals might contribute to diabetes-induced endothelial dysfunction. Because of this uncertainty, we performed a detailed and comprehensive evaluation of the potential of oxygen-derived free radical species involved in endothelial dysfunction in the diabetic rat aorta.
Methods
This investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US Ž National Institutes of Health NIH Publication No. 85-23, . Ž revised 1985 . Adult male Sprague-Dawley rats ap-. proximately 90 days of age were anesthetized with intraperitoneal injection of 60 mgrkg sodium pentobarbital. Diabetes was induced in anesthetized animals by an intra-Ž venous tail-vein injection of streptozotocin 55 mgrkg in . 0.1 M citrate buffer, pH 4.5 . A drop of tail blood was obtained at 1 week after administration of streptozotocin to verify hyperglycemia using a glucometer. Diabetic and age-matched control rats were housed for 2 months before experiments were conducted.
On the day of experimentation, rats were anesthetized with 65 mgrkg sodium pentobarbital. Descending thoracic aortae were carefully isolated, removed and placed in 48C Krebs' bicarbonate buffer. The aortic segments were carefully cleaned of fat and loose connective tissue and sectioned into 3-mm-long rings. In all instances, extreme care was taken to avoid stretching and contact with the luminal surface to avoid damage to the endothelium during isolation. In some rings, the endothelium was intentionally removed by placing a forceps within the lumen of the ring and gently rotating on blotting paper. Such a technique was verified to remove the endothelial cell surface based upon the absence of vasodilator response to 10 mM acetylcholine.
Isolated Õascular ring experiments
Aortic rings were suspended between parallel hooks in 10-ml tissue baths which were thermoregulated at 378C. The medium consisted of a modified Krebs-Henseleit bi-Ž . carbonate buffer containing in mM NaCl 118, KCl 4.7, CaCl 1.2, MgSO 12, glucose 11 and NaHCO 24 main- 2 4 3 tained at pH 7.4 with 95% O r5% CO . The medium 2 2 contained 0.8 mM imipramine and 0.9 mM propranolol to control for any potential differences in diabetes-induced changes in catecholamine content or action during experiments. In a few selected experiments, the glucose concentration was altered to 5.5 and 25 mM for control and diabetic rings to mimic the in vivo diabetic condition. Glucose was adjusted to these concentrations 5 min prior to addition of the constrictor agent and vasodilator as described below. Resting tension was set at an optimal level of 2.0 g for both control and diabetic blood vessels based upon length-tension studies. Changes in isometric tension were recorded on a Gould 6000 recorder via Radnoti force-displacement transducers except for the indomethacin and daltroban studies which used a Grass recorder and FTO3C transducers. At the completion of each experiment, the rings were blotted dry, weighed and the lengths were measured to calculate tension as normalized for cross-sec-Ž 2 . tional area by the formula: cross-sectional area mm s Ž . w Ž . x weight mg = length mm = density with the density of vascular smooth muscle being 1.05 mgrmm 3 as previw x ously described 17 .
IndiÕidual protocols
Each ring was equilibrated for 1 h. Concentration-response curves to increasing concentrations of norepinephrine were performed on each ring. Stock solutions of norepinephrine contained 20 nM ascorbate to prevent auto-oxidation. After generating norepinephrine contraction response curves, each ring was serially washed to tractile responses were calculated for each individual ring. Rings were then contracted with a submaximal concentration of norepinephrine which elicited approximately 70% of the maximum response. This concentration was usually 1 mM but was varied, if necessary, to achieve equieffective agonist activity. In a few selected experiments, phenylephrine was used as the constrictor agent. At the plateau of tension development to norepinephrine, concentration-dependent relaxation responses to acetylcholine or nitroglycerin were used to evaluate endothelium-dependent versus endothelium-independent vasodilation, respectively. Only one vasodilator was used for each ring preparation. For the acetylcholine experiments, rings were challenged with this agonist twice interspersed by washing, equilibration and re-exposure to the contracting agent. We have previously documented that this technique produces reproducible relaxation responses between the first and second challenge to acetylcholine in both w x control and diabetic rat aorta 18, 19 . Using this technique, any potential differences in intravessel reactivity can be minimized and each ring can serve as its own control. This is important in order to evaluate better the effect of intervention of facilitators or inhibitors of EDRF activity. In contrast, it was necessary to perform the experiments with nitroglycerin in the presence or absence of various drugs in parallel rings because of altered responsiveness with repetitive exposure to nitroglycerin. Furthermore, in additional studies performed under conditions which mim-Ž icked in vivo glucose conditions i.e., 5.5 and 25 mM . glucose for control and diabetic rings, respectively , the vasodilations were performed in pair-matched parallel rings from the same individual animals rather than in a pretestrpost-test format. This was done in order to determine the effect of antioxidants on the acute direct effect of elevated glucose.
Rings were incubated with 100 mM of L-nitroarginine Ž methyl ester or L-nitroarginine both nitric oxide synthase . Ž inhibitors , 10 mM indomethacin a cyclo-oxygenase in-. Ž hibitor or 30 mM daltroban a thromboxane receptor . antagonist for 20 min prior to contraction with norepinephrine to determine a role of nitric oxide or prostaglandin synthesis, respectively, in the relaxation responses of acetylcholine or, in some instances, nitroglycerin. To determine a role of oxygen-derived free radicals in defective endothelium-dependent relaxation, various agents were Ž . used including: CuZnSOD or MnSOD 20 or 150 Urml ; Ž . Ž . mannitol 50 mM ; catalase 100 Urml ; SOD plus cata-Ž . lase 20 and 100 Urml, respectively ; and diethylenetri-Ž . aminepentaacetic acid DETAPAC, 50 or 100 mM . Each of these agents was given 5 min prior to constriction with norepinephrine.
Data were analyzed by analysis of variance followed by Fisher's PLSD test for multiple mean comparisons or unpaired t-test for comparisons of two group means or paired t-test for comparisons of two group means in a pre-testrpost-test format. A value of P -0.05 was set to denote statistical significance.
Results

Characteristics of diabetic animals
Ž
. A total of 108 animals controls 52; diabetics 56 were used for this study. Control animals gained weight from 396 " 5 to 539 " 9 g at the end of the study while diabetic animals weighed 389 " 4 and 360 " 10 g at the start and end of the study, respectively. Blood glucose concentrations at the end of the study were 68 " 3 mgrdl in control versus 385 " 10 mgrdl in diabetic animals.
Vascular reactiÕity studies
Contraction-response curves to increasing concentrations of norepinephrine were generated for both control and diabetic rings with or without endothelium. The maxi-Ž . mum tension development in g was decreased in diabetic Ž rings compared to control rings with endothelium Table  . 1 but not when maximum tension development was normalized for cross-sectional area. Diabetes did not alter the Ž . sensitivity i.e., pD to norepinephrine. The effects of 2 removal of endothelium on tension development were also measured in a subset of animals in which rings were contracted with norepinephrine in parallel, pair-matched rings with or without endothelium. Removal of the endothelium caused an increase in maximum tension devel-Ž . opment in both control and diabetic rings Fig. 2 . The increase as a consequence of removal of the endothelium was nearly twice as great in control versus diabetic rings. For studies evaluating endothelium-dependent relaxation to acetylcholine, a submaximal concentration of norepinephrine was chosen which produced equipotent con-Ž traction in control versus diabetic rings i.e., 70 " 2 and 73 " 1% of maximal response in control and diabetic . rings, respectively . The average mean response of all rings from individual animals for the first challenge to acetylcholine was significantly reduced in diabetic rings Ž . Ž Fig. 3 , upper panel . Both maximum relaxation controls . Ž 86 " 2%; diabetics 70 " 3%, P -0.01 and pD control 2 . s 6.7 " 0.3; diabetics 6.3 " 0.1, P -0.01 for acetylcholine were altered by diabetes. . controls 5.5 mM; diabetics 25 mM glucose , maximum relaxation to acetylcholine in diabetic rings remained sig-Ž nificantly reduced control: 86 " 3% vs. diabetics 70 "
. Ž . 3%, P -0.01 Fig. 3 , middle panel . In addition, the pD 2 Ž for acetylcholine was also changed controls 6.2 " 0.1;
. diabetics 5.6 " 0.1, P -0.01 .
Additional experiments using the standard buffer conditions were performed in which phenylephrine rather than norepinephrine was used as the constrictor agent. Since Ž diabetes altered both the maximum tension controls 1.49 . " 0.08 g, diabetics 1.08 " 0.09 g; P -0.01 and the pD 2 Ž for phenylephrine controls 6.4 " 0.1, diabetic 6.1 " 0.1;
. P -0.05 , equipotent concentrations of agonist were used for the relaxation studies. Similar to the results obtained with norepinephrine, the relaxation induced by acetylcholine in phenylephrine-contracted rings was also im-Ž paired in diabetic rings compared to control rings Fig. 3 , . lower panel . While maximum relaxation was unaltered Ž . controls 105 " 1; diabetics 101 " 3% , there was a significant difference in the pD for acetylcholine in phenyl-2 Ž ephrine-contracted rings controls 7.3 " 0.0; diabetics . 7.0 " 0.1, P -0.05 . All additional experiments were performed using the physiologically-relevant agonist, norepinephrine. . Urml on acetylcholine-mediated relaxation in control and diabetic rat aorta. Each point represents the mean"s.e.m.
‡ P -0.01 for control vs.
diabetic rings by analysis of variance. The magnitude of relaxation response to acetylcholine in diabetic rings was not altered by indomethacin treatment Ž or daltroban i.e., % residual tone was 50 " 5% and 44 " 6% before and after indomethacin, n s 13; and 60 " 8% . and 54 " 6% before and after daltroban, n s 10 . Furthermore, addition of acetylcholine to diabetic rings under Ž . resting tension i.e., in the absence of norepinephrine did Ž not reveal any measurable increase in resting tension not . shown, n s 5 . The acetylcholine-induced relaxation of both control and diabetic rings was prevented after prein- cubation with either L-nitroarginine methyl ester or L-Ž . nitroarginine not shown .
In contrast to the results using acetylcholine, the endothelium-independent relaxation to nitroglycerin in rings without endothelium was not significantly altered by dia-Ž betes e.g., maximum relaxations 98 " 1 and 95 " 2% and pD s 7.5 " 0.1 and 7.3 " 0.1 for control and diabetic 2 . rings, respectively; n s 10 each . In addition, relaxation elicited by nitroglycerin was unaltered by L-nitroarginine in both control and diabetic rings either in the presence or Ž . absence of endothelium not shown .
In preliminary studies, we observed that addition of either CuZnSOD or MnSOD up to 150 Urml depressed contractile responses to norepinephrine in both control and Ž diabetic rings e.g., for diabetic rings before SOD, 
Ž . Ž significantly P -0.01 increased from 75 " 5% before . Ž treatment and 96 " 2% after treatment with SOD plus . catalase . In addition, SOD plus catalase changed the pD 2 Ž for acetylcholine i.e., 5.9 " 0.1 vs. 6.7 " 0.2, before and . after treatment of individual rings, respectively, P -0.01 . This augmented response was not seen when SOD plus Ž . catalase was given to control rings Fig. 5 , upper panel .
The impaired relaxation to acetylcholine in diabetic rings was also augmented by preincubation with either 50 Ž or 100 mM of the chelator, DETAPAC Fig. 6 , middle and . Ž lower panels . Maximum relaxation was significantly P . Ž . -0.01 increased from 74 " 4% before treatment to 93 " 1% and 100 " 1% after 50 mM and 100 mM DETA-Ž PAC, respectively. Also, the pD was significantly P -2 .
Ž . 0.01 shifted from 6.2 " O.1 before treatment to 6.8 " 0.1 and 7.0 " 0.1 for 50 and 100 mM DETAPAC, respectively. DETAPAC did not alter the relaxation to acetyl-Ž . choline in control rings Fig. 6 , upper panel . In control rings with endothelium, DETAPAC did not alter tension Ž development in response to norepinephrine in untreated, . 2.11 " 0.21 g; 50 mM DETAPAC, 1.99 " 0.22 g . In diabetic rings with endothelium, tension development to norepinephrine for the vasodilator studies was unaltered by Ž 50 mM DETAPAC untreated, 1.86 " 0.14 g; DETAPAC, . 1.71 " 0.14 g but was reduced by 100 mM DETAPAC Žuntreated, 1.88 " 0.08 g; DETAPAC, 1.45 " 0.08 g, P -. 0.01 .
Additional studies using scavenger intervention were performed in diabetic rings under elevated glucose conditions which mimic the in vivo environment. Similar to the results described above, both SOD plus catalase and DE-Ž . T A PA C significantly P -0.01 augm ented Ž . acetylcholine-induced relaxation of diabetic rings Fig. 7 . Ž . Maximum relaxation was 79 " 5% before treatment and 95 " 3% and 101 " 3% after treatment with SOD plus catalase and DETAPAC, respectively. The pD was also 2 Ž . changed from 6.3 " 0.2 before treatment to 7.0 " 0.1 and 7.1 " 0.1 after treatment with SOD plus catalase and DE-TAPAC, respectively.
The use of SOD or catalase alone did not alter the maximum relaxation or sensitivity to nitroglycerin in con-Ž . trol or diabetic rings with endothelium not shown . Furthermore, the combination of SOD plus catalase did not alter either the maximum relaxation or sensitivity to nitro-Ž glycerin in control rings with or without endothelium DETAPAC did not alter either relaxation or sensitivity to nitroglycerin in control rings either with or without Ž . endothelium Fig. 9 , left panels . In diabetic rings with or without endothelium, maximal relaxation to nitroglycerin Ž . was unaltered by DETAPAC Fig. 9 , right panels . In contrast, the sensitivity to nitroglycerin was augmented in Ž . diabetic rings with endothelium L-nitroarginine treatment, the pD for nitroglycerin was 2 7.5 " 0.1 and 7.6 " 0.1 in pair-matched diabetic rings without and with treatment with SOD plus catalase and 7.7 " 0.1 and 7.7 " 0.1 in pair-matched diabetic rings without and with treatment with DETAPAC.
Discussion
Oxygen radicals and reactive oxygen species play an important role in regulating endothelium-dependent relaxw x y ation 20,21 . For example, PO interacts directly with 2 Ž . w x nitric oxide NO to reduce its biological activity 22 and w x causes contraction of vascular smooth muscle 23 . In contrast, H O , a secondary non-radical reactive oxygen 2 2 w x species, is a vasodilator 6,23 and activates purified soluw x ble guanylate cyclase 24 . Another secondary oxygen radical species, the highly toxic POH, is believed to elicit w x contraction of vascular smooth muscle 25 . short-term diabetic rats. Furthermore, studies using SOD suggest that PO y plays an important role in regulating 2 w x spontaneous NO release by diabetic arteries 15,28 . It is unclear whether PO y has an equivalent impact on 2 agonist-stimulated NO activity arising from diabetic endothelium wherein larger amounts of NO are produced. Some previous studies demonstrated that SOD could reverse the impaired endothelium-dependent relaxation of w x both conduit and resistance diabetic arteries 10,16,29,30 w x while others showed that SOD was ineffective 31,32 . Interestingly, one group of investigators who showed SOD w x to be ineffective 32 previously showed that SOD imw x proved relaxation in diabetic mesenteric arteries 10 . Reasons for these discrepancies might include: species or strain differences; differences in mechanisms of dysfunction in various vascular beds of the same species; or variation in the experimental conditions. These results underscore the possibility that multiple mechanisms or factors may contribute to diabetic endothelial dysfunction and that it is hazardous to extrapolate conclusions found in one blood vessel type or species to another.
Role of superoxide anion radicals
In this regard, relaxation produced by certain endothelium-dependent agonists in certain types of blood vessels Ž . e.g., renal and mesenteric arteries have a significant component which is not blocked by inhibitors of NO w x synthase 11,32,33 . The fact that impaired relaxation can persist in certain diabetic blood vessels in the presence of w x these inhibitors 10,33 suggests that the dysfunction might Ž also be related to NO-independent factors e.g., endothe-. lium-derived hyperpolarizing factor or prostaglandins in some preparations. For this reason, studies which focus on the interaction of oxygen radicals with endothelium-de- 
The aorta of the diabetic rat is ideally suited for these Ž . purposes since a changes in hyperpolarizing factor apw x Ž . pear not to contribute to defective relaxation 34 ; b cyclo-oxygenase inhibitors do not improve endothelial w x function 5,35 similar to that shown in resistance vessels w x Ž . 10,36 ; and c NO synthase inhibitors completely block acetylcholine-induced relaxation in aortic rings of both ww x x control and diabetic rats 18,19 ; and in this study . Thus, the success or failure of SOD to improve relaxation in diabetes could depend on the relative contribution of NO versus other relaxing factors which might contribute to the total acetylcholine-mediated relaxation.
Because of such limitations in previous studies, we conducted a more rigorous re-evaluation of the role of PO y and other reactive oxygen species on agonist-stimu-2 lated endothelial dysfunction in diabetes. Precaution must be taken using SOD since it causes significant relaxation of preconstricted rings with endothelium but not without endothelium and this relaxation is enhanced in diabetic w x rings 15 . In the initial experiments, it could be argued that the change in constrictor tone caused by 150 Urml SOD contributed to the improved relaxation of diabetic rings to acetylcholine. One investigator adjusted the concentration of norepinephrine in SOD-exposed rings to adjust for this technicality and observed that the previous beneficial effect of SOD on acetylcholine-mediated relaxation in diabetic renal resistance arteries was no longer w x apparent 32 . Similarly, we observed that reducing SOD to 20 Urml to prevent changes in norepinephrine-induced tension resulted in a failure to augment relaxation to acetylcholine. It cannot be argued that this activity of SOD was inadequate to scavenge PO y since we have shown 2 that the same activity normalized acetylcholine-induced relaxation in aorta from the spontaneous diabetic BB rat w x 37 although the possibility cannot be excluded that BB rats are more sensitive to SOD. Collectively, these observations suggest that PO y alone may be insufficient to 2 account for all of the endothelial dysfunction in diabetic rat aorta.
( ) 4.2. Role of secondary reactiÕe oxygen species H O 2 2
Most previous studies do not allow one to discriminate whether PO y or other secondary reactive oxygen species 2 play important roles in endothelial dysfunction of diabetic conduit blood vessels. Thus, our study provides new and important insights in this area. When using SOD only, one must exclude the possibility that SOD-induced improvement in relaxation is not simply due to augmenting the production of the H O , since 2 2 exogenous H O itself can cause relaxation which is 2 2 w x enhanced in diabetic rat aorta 6 . To test this contingency, the addition of catalase with SOD should cause an impaired relaxation. Since we did not observe any such impairment with SOD plus catalase versus SOD alone, this hypothesis is discounted. Rather, we observed a marked increase in acetylcholine-induced relaxation of diabetic aorta when the combination of scavengers were used. These results suggest a cooperative role of both PO y and 2 H O in diabetes-induced endothelial dysfunction. Fenton reaction Ž .
Haber y Weiss reaction Ž .
In the present study, DETAPAC, a metal ion chelator and inhibitor of POH formation via the Fenton reaction, augmented acetylcholine-mediated relaxation only in diabetic rings. The observation that this effect occurred at concentrations which either caused no change or depressed norepinephrine-induced tension indicates that the salient effect of DETAPAC on relaxation was independent of action on preconstrictor tone. Our results using DETAPAC are consistent with our SOD plus catalase studies and support the concept of enhanced metal-catalyzed POH formation in diabetes. Thus, reduction in POH, a putative w x vasoconstrictor 25 , might explain the restoration of impaired relaxation in diabetic rings using either SOD plus catalase or DETAPAC.
It is important to note that both SOD plus catalase and DETAPAC did not alter reactivity to either acetylcholine or nitroglycerin in control rings but in diseased aortic rings. Thus, these interventions do not have intrinsic properties to alter vascular reactivity. The fact that both SOD plus catalase and DETAPAC augmented relaxation to ni-Ž troglycerin in diabetic rings with endothelium but not in . control rings with endothelium unmasks an additional component of nitroglycerin-induced relaxation which is specifically modified by scavenger-treated diabetic endothelium. These observations are consistent with enhanced production of both PO y and H O from diabetic 2 2 2 endothelium which might limit the relaxation produced by nitroglycerin. This interaction could occur possibly by reduction in the NO formed from metabolism of nitroglycerin or by enhancing basal NO synthesis or release from the endothelium or inhibiting enhanced breakdown of basal NO production. The fact that both scavenger interventions failed to alter reactivity to nitroglycerin in de-endothelialized diabetic rat aorta supports the notion that neither SOD plus catalase at Pennsylvania State University on February 23, 2013 http://cardiovascres.oxfordjournals.org/ Downloaded from ( )nor DETAPAC had any capacity to directly alter the intrinsic reactivity of diabetic vascular smooth muscle and that there is no direct effect of these interventions on thiol-dependent metabolism of nitroglycerin which could account for the augmented response to nitroglycerin after scavenger treatment of endothelium-intact diabetic rings. This conclusion was confirmed by our studies in which both scavenger interventions failed to augment relaxation to nitroglycerin in nitroarginine-treated diabetic rings with endothelium. Also, the failure of DETAPAC to shift responses to nitroglycerin in control but not diabetic rings indicates that the diabetic endothelium is the source of POH or the precursors for POH formation. Collectively, our results suggest that the salient action of both SOD plus catalase and DETAPAC on endothelium-dependent relaxation of diabetic rings has an obligatory requirement for both the endothelium and a functioning NO synthase.
The nitroarginine experiments were particularly insightful because these results suggest that the PO y and H O 2 2 2
formed from diabetic endothelium might even arise from an aberrant NO synthase pathway. In this regard, previous studies using purified NO synthase have shown increased PO y and H O production under conditions of suboptimal
concentrations of substrate, L-arginine, or co-factor, tetraw x hydrobiopterin 39,40 . This is consistent with our previous studies showing that replenishment of substrate and co-factor for NO synthase by addition in vitro with L-arginine w x w x 18,19 or a tetrahydrobiopterin derivative 41 restored acetylcholine-induced relaxation in diabetic aorta.
Extracellular Õs. intracellular actions of scaÕengers
Ž It is interesting that mannitol an extracellular POH . scavenger failed to improve relaxation of diabetic rings to acetylcholine suggesting that POH radicals are generated Ž intracellularly; yet, SOD plus catalase large molecules . presumably confined to the extracellular space was also effective in improving relaxation. These need not be inconsistent observations. It is well-known that endothelial cells can release both PO y and H O ; however, it is unclear which are likely to be released from the endothelium, can w x form peroxynitrite 42 . Peroxynitrite due to its longer half-life and greater diffusion distance might enter vascular smooth muscle cells. Therein, the decomposition product of peroxynitrite, POH, would be unavailable to scavenging by mannitol. Thus, while the endothelium might be an obligatory source of initial production of reactive oxygen, other reactive oxygen species might be formed andror produced in adjacent vascular smooth muscle cells in diabetes. The hypothesized requirement of the endothelium Ž y as a source of initial reactive oxygen species i.e., PO 2 . and H O is strengthened by our studies in which SOD 2 2 plus catalase or DETAPAC augmented the relaxation of diabetic rings to nitroglycerin only in the presence of the endothelium.
It is noteworthy that intravenously-applied SOD failed to normalize dilation to acetylcholine while topical application of a combination of SOD plus catalase normalized the impaired responses in intact coronary arterioles of w x alloxan-diabetic dog 43 , which agrees with our results using combination intervention. In addition, those studies suggest that reactive oxygen species might also be generated from non-endothelial sources under in vivo conditions. Clearly, many important questions still need to be resolved concerning the precise location and source of reactive oxygen production in diabetic blood vessels including the interaction of various cell types before any definitive conclusions can be made.
Additional notes and clinical implications
We used norepinephrine to contract blood vessels because it is a physiologically-relevant agonist. We acknowledge the hypothesis that defective endothelium-dependent relaxation of diabetic aorta might result from the choice of agonist chosen. This hypothesis is based upon the presumption that norepinephrine, a dihydroxyphenyl derivative which is subject to autoxidation in oxygenated buffer, is a source of oxygen radicals which might limit nitricw x oxide-mediated, endothelium-dependent relaxation 44 . We find this hypothesis unlikely for several reasons. First, auto-oxidation of norepinephrine should be limited by the inclusion of ascorbate. Secondly, if auto-oxidation were a problem, the addition of SOD alone should have improved relaxation by scavenging the PO y generated 2 during auto-oxidation. Thirdly, we designed additional experiments which showed that endothelial dysfunction was still present in diabetic rings which had been precontracted with phenylephrine, a synthetic monohydroxyphenyl derivative which is not prone to auto-oxidation. Our observations using phenylephrine are consistent with the endothelial dysfunction observed by numerous investigators w x using various rat artery preparations 11, 26, 35, 45, 46 . This suggests that endothelial dysfunction is independent of the agonist chosen. Finally, that our experimental studies evaluating various antioxidant intervention in diabetic models may have clinical significance was emphasized in a recent study in which acute administration of the antioxidant, 
In summary, our studies support the notion that enhanced POH formation likely plays a significant role in diabetes-induced endothelial dysfunction.
